EUVIMEDEUVIMED entdecken
Open Access

Medication use during pregnancy in Japan from 2005 to 2019: Trends and safety considerations

Motohiko Adomi iD, Takamasa Sakai, Tomofumi Ishikawa, Taku Obara, Krista F Huybrechts

International Journal of Gynecology & Obstetrics · 2026-08 · 174 (2) · 1016-1024

DOI: 10.1002/ijgo.70860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 07.03.2026. Verfasst von Motohiko Adomi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Pregnancy Complications, Drug Utilization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Harvard T.H. Chan School of Public Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Recent data on patterns and trends of medication use during pregnancy are limited in Japan. This study aimed to evaluate annual trends of medication use during pregnancy in Japan and identify frequently dispensed medications with limited safety evidence.

Methods

A descriptive study was conducted using a pregnancy cohort nested within the JMDC claims database (2005–2019). Dispensing of medications before pregnancy and during each pregnancy trimester were evaluated. Annual trends were examined at the class and subclass medication level. Availability of evidence on teratogenic risk was assessed for the top 30 most commonly dispensed medications during the first trimester using the TERIS database.

Results

A total of 110 969 pregnancies (94 749 unique individuals) were included in the study. Acetaminophen was the most commonly dispensed medication across all windows. Other frequently dispensed medications included other analgesics, antiasthmatics, antibiotics, antiemetics, antiulcer medications, immunosuppressants, and thyroid medications. Annual trends revealed increased dispensing of analgesics (primarily acetaminophen), antiasthmatics (inhaled beta‐2 agonists, inhaled corticosteroids, leukotriene receptor antagonists), antiemetics (metoclopramide), and thyroid medications (thyroid hormone). Over 60% of the 30 most commonly dispensed medications during the first trimester lacked sufficient teratogenic safety evidence, particularly for antiasthmatics, antibiotics, and antivirals.

Conclusion

A significant proportion of medications commonly dispensed during pregnancy in Japan have inadequate teratogenic safety evidence. Several medication classes showed increasing utilization trends over the study period, emphasizing the urgent need for targeted safety evaluations in the Japanese population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy ComplicationsDrug UtilizationHumansFemalePregnancyJapanAdultDatabases, FactualAcetaminophenTeratogensPregnancy TrimestersAbnormalities, Drug-Induced

Stichwörter der Autor:innen

Japandrug utilizationpregnancyteratogenicity

Substanzen

AcetaminophenTeratogens

Autor:innen und Institutionen

  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Drug Informatics, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
  • Laboratory of Biomolecule and Pathophysiological Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • Division of Molecular Epidemiology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

ORCID-Profile: Motohiko Adomi

Förderung

  • Harvard T.H. Chan School of Public Health

Zitieren

APA

Adomi, M., Sakai, T., Ishikawa, T., Obara, T., & Huybrechts, K. F. (2026). Medication use during pregnancy in Japan from 2005 to 2019: Trends and safety considerations. International Journal of Gynecology & Obstetrics, 174(2), 1016-1024. https://doi.org/10.1002/ijgo.70860

Vancouver

Adomi M, Sakai T, Ishikawa T, Obara T, Huybrechts KF. Medication use during pregnancy in Japan from 2005 to 2019: Trends and safety considerations. International Journal of Gynecology & Obstetrics. 2026;174(2):1016-1024. doi:10.1002/ijgo.70860

BibTeX
@article{Adomi2026,
  author = {Adomi, Motohiko and Sakai, Takamasa and Ishikawa, Tomofumi and Obara, Taku and Huybrechts, Krista F},
  title = {Medication use during pregnancy in Japan from 2005 to 2019: Trends and safety considerations},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2026},
  volume = {174},
  number = {2},
  pages = {1016--1024},
  doi = {10.1002/ijgo.70860}
}
Kostenlos starten →